I was in heart failure.” ‘I was in bed for a year’ Jensen-Munroe said she was “absolutely stunned” when told she likely had ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

A head-to-head trial of HexaBody-CD38 versus Darzalex Faspro revealed an overall response rate (ORR) of 55% and 52%, respectively, with Genmab pointing to "deeper responses" with the new drug and a ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined IQVIA to conduct the bioequivalence study or present safety data for ...

A key advance in SMM last year was the AQUILA trial. Many believe it is clear that daratumumab has demonstrated improved survival in SMM. However, I believe this survival result to be implausible ...

Johnson & Johnson has claimed FDA approval for new formulation of its blockbuster multiple myeloma drug Darzalex that cuts its dosing time to just a few minutes from hours and could help it fend ...

Morningstar brands and products Company Portfolio ...

EU and CN sourced daratumumab. The company is now conducting comparative efficacy studies.

trametinib or both for treating BRAF V600 mutation-positive unresectable or metastatic melanoma in people aged 12 and over [TSID11838] Technology appraisal guidance Daratumumab for treating high-risk ...

Jensen-Munroe relapsed in 2023 and was told unfunded, $220,000-a-year drug daratumumab was her “best option”. Unable to afford that, last year she took the second option of a stem cell transplant.

has entered into a licence agreement with Shanghai Henlius Biotech Inc for the development and commercialisation of the Chinese player’s investigational daratumumab biosimilar candidate HLX15.